SCGB1D4 and essential thrombocythemia: It is to be noted that the hFUS-Q290X mutation was identified in patients having early onset ET, and our data show that overexpression of hFUS-Q290X resulted in prolonged life span which was accompanied by downregulation of the IIS/TOR signalling pathway.